Skip to main content
. 2020 Aug 31;22(8):e18100. doi: 10.2196/18100

Table 4.

Subgroup analyses: depression treatments.

Subgroup analysisa Effects Heterogeneity Subgroup analysis

Nb g 95% CI I2 P value I2 95% CI Q value P value (Q)
Recruitment pathwayc

Clinical and community+clinical 8 1.05 0.95-1.14 78 <.001 56-89 7.253 .007

Community 5 1.38 1.16-1.59 96 <.001 94-98 7.253 .007
Specific treatment

Mixed treatment 7 1.10 0.98-1.22 93 <.001 87-96 0.736 .39

Disorder-specific treatment 6 1.27 0.91-1.62 97 <.001 95-98 0.736 .39
Diagnosis conductedd

Interview 7 1.127 0.89-1.35 97 <.001 95-98 0.946 .33

Questionnaire 5 1.25 1.16-1.34 81 <.001 57-92 0.946 .33
Clinical cutoff/minimal symptom severity

Yes 4 1.27 1.08-1.45 84 <.001 60-94 0.897 .34

No 7 1.17 0.98-1.35 96 <.001 94-97 0.897 .34
Treatment duration

<9 weeks 5 1.17 1.01-1.32 95 <.001 92-97 7.485 .02

9-13 weeks 4 1.00 0.95-1.05 0 .85 0-85 7.485 .02

>13 weeks 4 1.37 1.00-1.74 97 <.001 94-98 7.485 .02
Guide cognitive behavioral therapy training (profession)e

Nonprofessional 4 0.92 0.79-1.05 22 .28 0-88 14.151 <.001

Other 9 1.27 1.14-1.40 96 <.001 94-97 14.151 <.001
Guide supervision provided

No 4 0.91 0.75-1.08 39 .18 0-79 10.339 <.001

Yes 9 1.27 1.13-1.41 96 <.001 94-97 10.339 <.001
Guide training provided

No 6 0.98 0.94-1.02 7 .37 0-76 21.368 <.001

Yes 7 1.35 1.20-1.51 95 <.001 91-97 21.368 <.001
Intervention manual provided

No 9 1.039 0.95-1.137 75 <.001 51-87 10.715 <.001

Yes 4 1.467 1.23-1.71 97 <.001 95-98 10.715 <.001
Risk of bias—researcher allegiance

High 7 1.252 1.08-1.42 97 <.001 95-98 1.347 .25

Low 5 1.119 0.99-1.29 70 .01 23-88 1.347 .25
Risk of bias—confounding (treatment inclusion)

High 7 1.215 1.06-1.43 96 <.001 94-98 0.985 .32

Low 5 1.105 0.98-1.23 82 <.001 58-92 0.985 .32

aTest against “Guidance format: face-to-face vs written guidance,” “Guidance modality: Message, Email, Telephone, F2F,” and “Guide profession” excluded, as there were too few studies included in analysis.

bNumber of studies.

cOnly two studies included via the clinical pathway only. We combined the categories “Both, community and clinical” and “clinical” for this analysis.

dExcluding one study [54], as this is the only study using clinical judgment without specifying the use of an interview or questionnaire.

eWe grouped all studies involving guides not specifically trained in delivering cognitive behavioral therapy in the category “non-professional” and studies involving psychiatrists, psychologists, or psychotherapists in their guidance in the category “other.”